Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

December 27, 2027

Conditions

Repetitive Head Impacts

Interventions

DRUG

Gamma-glutamylcysteine (GGC)

400mg tablet orally (two times) per day.

Trial Locations (1)

RECRUITING

UPMC Presbyterian Hospital, Pittsburgh

All Listed Sponsors

collaborator

Chuck Noll Foundation

UNKNOWN

lead

Pravat Mandal

OTHER